Evofem Biosciences, Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Evofem Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q2 2024.
  • Evofem Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.39M, a 81.1% increase year-over-year.
  • Evofem Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$11.2M, a 73.2% increase year-over-year.
  • Evofem Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$17.8M, a 78.8% increase from 2022.
  • Evofem Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$84.1M, a 49.6% increase from 2021.
  • Evofem Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$167M, a 61% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$11.2M -$1.39M +$5.95M +81.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$17.1M -$2.84M +$735K +20.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$17.8M -$3.38M +$8.67M +72% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$26.5M -$3.55M +$15.2M +81% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$41.7M -$7.34M +$17.1M +70% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$58.8M -$3.58M +$25.4M +87.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$84.1M -$12.1M +$25.4M +67.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$109M -$18.7M +$24.6M +56.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$134M -$24.4M +$16.7M +40.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$151M -$28.9M +$15.9M +35.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-06-16
Q4 2021 -$167M -$37.4M -$1.57M -4.37% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-27
Q3 2021 -$165M -$43.4M -$17.2M -65.8% Jul 1, 2021 Sep 30, 2021 10-Q 2023-01-06
Q2 2021 -$148M -$41.1M -$18.8M -83.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$129M -$44.9M -$25.6M -133% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$104M -$35.9M -$23M -179% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$80.6M -$26.2M -$11.9M -82.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$68.8M -$22.4M -$10.4M -87.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$58.4M -$19.2M -$5.61M -41.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$52.7M -$12.9M +$2.11M +14.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$54.9M -$14.3M +$4.14M +22.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$59M -$11.9M +$11.3M +48.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$70.3M -$13.6M +$7.35M +35% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$77.6M -$15M +$365K +2.38% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$78M -$18.4M -$9.36M -103% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$68.6M -$23.2M -$16.9M -266% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$51.8M -$21M -$16.1M -327% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$35.7M -$15.3M +$9.13M +37.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$44.8M -$9.07M -$7.2M -385% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$37.6M -$6.36M -$3.84M -152% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$33.8M -$4.91M +$868K +15% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$34.6M -$24.5M -$15.2M -165% Oct 1, 2016 Dec 31, 2016 8-K/A 2018-04-06
Q3 2016 -$19.4M -$1.87M +$15.1M +89% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$34.5M -$2.52M +$6.68M +72.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$41.2M -$5.78M +$857K +12.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$42M -$9.23M -$5.97M -183% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 -$36.1M -$17M -$15.1M -810% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$21M -$9.2M -$7.22M -364% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$13.7M -$6.64M -$4.15M -167% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$9.59M -$3.26M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-23
Q3 2014 -$1.87M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$1.98M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$2.48M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.